Pardes Biosciences logo

Pardes Biosciences

Carlsbad, CA

Pardes Biosciences is a biotechnology company that develops and commercializes direct-acting antivirals for the treatment of coronavirus. The Carlsbad, California-based company was established by Uri Lopatin in 2020.

pardesbio.com

Company Details

Founded

2020

Employees

Between 20 - 100 employees

Raised

$126,614,992

Headquarters Location

Carlsbad, CA

Public

Yes

Acquired

Yes

CEO

Jim TananbaumJim Tananbaum

Founders

Uri Lopatin
Uri Lopatin

Company Collections

These are collections Pardes Biosciences is a part of. Click on the collection name to view similar companies.

Pardes Biosciences' Investors

Pardes Biosciences' Industries

Pardes Biosciences' Tech Stack

Pardes Biosciences Headquarters Location

2173 Salk Avenue suite 250 #052 Pmb, Carlsbad, CA 92008

Total Amount Raised: $126,614,992

Pardes Biosciences' Investors

Pardes Biosciences Funding Rounds

  • Post Ipo Equity

    $75,000,000

    Post Ipo Equity Investors

    Foresite Capital
    Monashee Investment Management
    RA Capital Management
    EcoR1 Capital
    Gilead Sciences
    GMF Capital
    Frazier Management
    T. Rowe Price

  • Undisclosed

    $51,614,997

    Undisclosed Investors

    Y Combinator

  • IPO

    Unknown

Funding info provided by Diffbot.

Pardes Biosciences Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Pardes Biosciences.

Recent reviews